Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients

Küçük Resim Yok

Tarih

2022

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Elsevier

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

Aim of the study. - STOPP/START criteria appear to be a useful tool to curb inappropriate prescribing (IP), which encompasses errors of both, over and under-treatment. This study aimed to find out whether application of STOPP/START reduces the IP effectively in primary care. Methods. - This prospective cross-sectional study was conducted in two family health centers (FHCs) in Istanbul. All older adults who applied to FHCs between 01-07-2018 and 01-072020 were enrolled. The potential inappropriate medications (PIMs) and potential prescription omissions (PPOs) were identified according to STOPP/START version 2 criteria. Mean drug consumptions before and after STOPP/START were compared using Student's t-test. Results. - Among 1023 participants there were 626 females and 397 males. The mean age was 73.33 +/- 7.30 years. The number of the patients seen at FHCs was 657 (64.2%) while 366 (35.8%) of them were visited at home. Of the patients, 383 (37.8) were 75 years old or older and 631 (62.2%) of them were under 75. Overall number of drugs consumed per patient was 5.49 +/- 3.93 while it was 6.01 +/- 3.71 and 4.55 +/- 4.138 for outpatients and home patients respectively (p < 0.001). By application of STOPP criteria, among the 5616 medications consumed by the overall patients, 881(%15.6) of them were found to be potentially inappropriate. 424 (41.4%) patients were using at least one PIM. This ratio was 354 (53.8%) in outpatients and 70 (19%) in home patients. START criteria identified 380 (%7.4) PPOs. There were 246 (24.0%) patients at least with one PPO; 155 (42.3%) of whom were home patients and 91 (13.8%) were outpatients. Regarding the age groups; PIM ratio was 35.5% in patients under 75 and 52.1% over 75 whereas PPO ratio was 22.5% under 75 and 26.8% over 75. Conclusion. - This study supports the data reporting the effectiveness of STOPP/START criteriain primary care units in implementing appropriate prescription criteria. (C) 2021 Societe francaise de pharmacologie et de therapeutique. Published by Elsevier MassonSAS. All rights reserved.

Açıklama

Anahtar Kelimeler

STOPP, START criteria, Rational drug use, Primary care, Polypharmacy, Under-treatment

Kaynak

Therapie

WoS Q Değeri

Q3

Scopus Q Değeri

Q2

Cilt

77

Sayı

3

Künye